South Korea vs Netherlands: Coverage of the human papillomavirus vaccine
South Korea
67
in 2025
Netherlands
66
in 2025
South Korea rank
45th
Netherlands rank
48th
Coverage of the human papillomavirus vaccine over time
- South Korea
- Netherlands
How they compare
South Korea currently reports 67 against 66 in Netherlands, a difference of 1.
The two have swapped places 5 times across 8 shared years of data; in 2018 it was Netherlands ahead.
South Korea ranks 45th and Netherlands ranks 48th of 85 countries.
South Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Korea | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.5 | 51.5 | 4 | South Korea |
| 2020s | 69 | 65.67 | 3.33 | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, South Korea or Netherlands?
- South Korea, at 67 against 66 in Netherlands as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between South Korea and Netherlands?
- 1, with South Korea ahead.
- How many years of comparable data are there for South Korea and Netherlands?
- 8 years are reported by both, from 2018 to 2025.
- How do South Korea and Netherlands rank globally for coverage of the human papillomavirus vaccine?
- South Korea ranks 45th and Netherlands ranks 48th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.